Centrum Medyczne ENEL-MED S.A. (WSE:ENE)
Poland · Delayed Price · Currency is PLN 19.60
+0.40 (2.08%)
Jul 24, 2026, 5:00 PM CET
Centrum Medyczne ENEL-MED Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 423.95 | 854.27 | 735.59 | 618.55 | 494.9 | 441.14 | |
Revenue Growth (YoY) | -25.74% | 16.13% | 18.92% | 24.98% | 12.19% | 10.36% |
Cost of Revenue | 383.21 | 774.62 | 677.09 | 592.59 | 484.02 | 421.12 |
Gross Profit | 40.74 | 79.65 | 58.51 | 25.96 | 10.88 | 20.02 |
Selling, General & Admin | 28.15 | 58.32 | 35.54 | 33.51 | 37.12 | 23.21 |
Other Operating Expenses | 2.05 | -2.49 | -4.98 | -10.54 | -5.39 | 1.44 |
Total Operating Expenses | 30.2 | 55.84 | 30.56 | 22.97 | 31.72 | 24.65 |
Operating Income | 13.68 | 23.81 | 27.95 | 2.99 | -20.84 | 1.73 |
Interest Income | -3.74 | 2.71 | 3.67 | 16.74 | 1.55 | 0.01 |
Interest Expense | -5 | -10.21 | -12.47 | -9.92 | -8.65 | -1.34 |
Other Non-Operating Income (Expense) | 3.14 | - | - | - | - | 6.35 |
Total Non-Operating Income (Expense) | -5.6 | -7.5 | -8.8 | 6.82 | -7.1 | 5.02 |
Pretax Income | 4.93 | 16.31 | 19.14 | 9.81 | -27.94 | 0.4 |
Provision for Income Taxes | 0.29 | 3.42 | 4.54 | 1.58 | -4.38 | 4.11 |
Net Income | 4.65 | 12.89 | 14.61 | 8.23 | -23.56 | -3.71 |
Net Income to Common | 4.65 | 12.89 | 14.61 | 8.23 | -23.56 | -3.71 |
Net Income Growth | 144.43% | -11.75% | 77.53% | - | - | - |
Shares Outstanding (Basic) | 28 | 28 | 28 | 28 | 28 | 28 |
Shares Outstanding (Diluted) | 28 | 28 | 28 | 28 | 28 | 28 |
Shares Change (YoY) | - | - | - | - | - | 20.00% |
EPS (Basic) | 0.28 | 0.46 | 0.52 | 0.28 | -0.83 | -0.05 |
EPS (Diluted) | 0.28 | 0.46 | 0.52 | 0.28 | -0.83 | -0.05 |
EPS Growth | -60.00% | -11.54% | 85.71% | - | - | - |
Free Cash Flow | 225.72 | 187.16 | 148.18 | 113.79 | 85.99 | 0 |
Free Cash Flow Growth | 78.98% | 26.30% | 30.23% | 32.32% | - | - |
Free Cash Flow Per Share | 7.98 | 6.62 | 5.24 | 4.02 | 3.04 | - |
Gross Margin | 9.61% | 9.32% | 7.95% | 4.20% | 2.20% | 4.54% |
Operating Margin | 3.23% | 2.79% | 3.80% | 0.48% | -4.21% | 0.39% |
Profit Margin | 1.10% | 1.51% | 1.99% | 1.33% | -4.76% | -0.84% |
FCF Margin | 53.24% | 21.91% | 20.14% | 18.40% | 17.38% | 0.00% |
EBITDA | 96.97 | 105.44 | 103.41 | 74.37 | 41.28 | 1.73 |
EBITDA Margin | 22.87% | 12.34% | 14.06% | 12.02% | 8.34% | 0.39% |
EBIT | 13.68 | 23.81 | 27.95 | 2.99 | -20.84 | 1.73 |
EBIT Margin | 3.23% | 2.79% | 3.80% | 0.48% | -4.21% | 0.39% |
Effective Tax Rate | 5.78% | 20.95% | 23.69% | 16.12% | 15.69% | 1030.08% |